{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:55:46Z","timestamp":1781326546706,"version":"3.54.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2024SF-YBXM-322"],"award-info":[{"award-number":["2024SF-YBXM-322"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960177"],"award-info":[{"award-number":["81960177"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82571233"],"award-info":[{"award-number":["82571233"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031934","name":"First Affiliated Hospital of Xi'an Jiaotong University","doi-asserted-by":"publisher","award":["2024-MS-22"],"award-info":[{"award-number":["2024-MS-22"]}],"id":[{"id":"10.13039\/100031934","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.exer.2025.110803","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T07:35:47Z","timestamp":1765265747000},"page":"110803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Canagliflozin inhibits NLRP3 inflammasome activation to protect the retinal neurovascular unit in a mouse retinal vein occlusion model"],"prefix":"10.1016","volume":"263","author":[{"given":"Jixian","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhou","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2025.110803_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113839","article-title":"Canagliflozin attenuates neurodegeneration and ameliorates dyskinesia through targeting the NLRP3\/Nurr1\/GSK-3\u03b2\/SIRT3 pathway and autophagy modulation in rotenone-lesioned rats","volume":"146","author":"Abdelaziz","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.exer.2025.110803_bib2","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/bjophthalmol-2015-308106","article-title":"In vivo evaluation of retinal ganglion cells degeneration in eyes with branch retinal vein occlusion","volume":"100","author":"Alshareef","year":"2016","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2025.110803_bib3","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1038\/s41467-020-16902-5","article-title":"Endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion","volume":"11","author":"Avrutsky","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.exer.2025.110803_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-0044-1791232","article-title":"Potential of sulodexide in the treatment of diabetic retinopathy and retinal vein occlusion","volume":"125","author":"B\u00f6hm","year":"2025","journal-title":"Thromb. Haemost."},{"issue":"10296","key":"10.1016\/j.exer.2025.110803_bib5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications","volume":"398","author":"Brown","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.exer.2025.110803_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","article-title":"The gasdermins, a protein family executing cell death and inflammation","volume":"20","author":"Broz","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.exer.2025.110803_bib7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41590-022-01255-6","article-title":"Allergen protease-activated stress granule assembly and gasdermin D fragmentation control interleukin-33 secretion","volume":"23","author":"Chen","year":"2022","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.exer.2025.110803_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41419-022-05387-3","article-title":"Neurovascular injury associated non-apoptotic endothelial caspase-9 and astroglial caspase-9 mediate inflammation and contrast sensitivity decline","volume":"13","author":"Col\u00f3n","year":"2022","journal-title":"Cell Death Dis."},{"issue":"14","key":"10.1016\/j.exer.2025.110803_bib9","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exer.2025.110803_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1011669","article-title":"Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy","volume":"13","author":"Du","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.exer.2025.110803_bib11","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1038\/s41598-025-91045-5","article-title":"Spatial distribution and functional integration of displaced retinal ganglion cells","volume":"15","author":"Duda","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.exer.2025.110803_bib12","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1167\/iovs.16-20474","article-title":"Microglia activation and recruitment of circulating macrophages during ischemic experimental branch retinal vein occlusion","volume":"58","author":"Ebneter","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110803_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ajo.2024.10.029","article-title":"Sodium-glucose cotransporter 2 inhibitors for the primary prevention of glaucoma in patients with type 2 diabetes: a target trial emulation","volume":"271","author":"Eng","year":"2025","journal-title":"Am. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2025.110803_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031362","article-title":"The effect of sodium-dependent glucose cotransporter 2 inhibitor tofogliflozin on neurovascular coupling in the retina in type 2 diabetic mice","volume":"23","author":"Hanaguri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110803_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100964","article-title":"Photocoagulation for retinal vein occlusion","volume":"85","author":"Hayreh","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"issue":"12","key":"10.1016\/j.exer.2025.110803_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.31083\/j.fbl2712321","article-title":"Determining the role of SGLT2 inhibition with dapagliflozin in the development of diabetic retinopathy","volume":"27","author":"Herat","year":"2022","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"4","key":"10.1016\/j.exer.2025.110803_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.31083\/j.fbl2804083","article-title":"Comparing and contrasting the effects of the SGLT inhibitors canagliflozin and empagliflozin on the progression of retinopathy","volume":"28","author":"Herat","year":"2023","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"19","key":"10.1016\/j.exer.2025.110803_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197413","article-title":"Pericyte-endothelial interactions in the retinal microvasculature","volume":"21","author":"Huang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110803_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101349","article-title":"Microglial regulation of the retinal vasculature in health and during the pathology associated with diabetes","volume":"106","author":"Jobling","year":"2025","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.exer.2025.110803_bib20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/glia.23739","article-title":"Inhibition of inflammatory cells delays retinal degeneration in experimental retinal vein occlusion in mice","volume":"68","author":"Jovanovic","year":"2020","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.exer.2025.110803_bib21","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/s41467-020-16043-9","article-title":"N-GSDMD trafficking to neutrophil organelles facilitates IL-1\u03b2 release independently of plasma membrane pores and pyroptosis","volume":"11","author":"Karmakar","year":"2020","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.exer.2025.110803_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110803_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.exer.2015.04.020","article-title":"The microglia in healthy and diseased retina","volume":"136","author":"Li","year":"2015","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.exer.2025.110803_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3773","article-title":"Association of sodium-glucose cotransporter-2 inhibitors and the risk of retinal vascular occlusion: a real-world retrospective cohort study in Taiwan","volume":"40","author":"Lin","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"10.1016\/j.exer.2025.110803_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-024-01958-2","article-title":"Pyroptosis in health and disease: mechanisms, regulation and clinical perspective","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10.1016\/j.exer.2025.110803_bib26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/17512433.2022.2102973","article-title":"The association between the use of sodium glucose cotransporter 2 inhibitor and the risk of diabetic retinopathy and other eye disorders: a systematic review and meta-analysis","volume":"15","author":"Ma","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.exer.2025.110803_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.12296","article-title":"Regulation of inflammasome activation","volume":"265","author":"Man","year":"2015","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.exer.2025.110803_bib28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00417-023-06273-0","article-title":"SGLT2 inhibitors and diabetic retinopathy progression","volume":"262","author":"Nadelmann","year":"2024","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"7","key":"10.1016\/j.exer.2025.110803_bib29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.exer.2025.110803_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12933-020-01071-y","article-title":"SGLT2i: beyond the glucose-lowering effect","volume":"19","author":"Ni","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.exer.2025.110803_bib31","article-title":"Cytokines and the pathogenesis of macular edema in branch retinal vein occlusion","volume":"2019","author":"Noma","year":"2019","journal-title":"J Ophthalmol"},{"issue":"11","key":"10.1016\/j.exer.2025.110803_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113457","article-title":"Cytokines and pathogenesis of central retinal vein occlusion","volume":"9","author":"Noma","year":"2020","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.exer.2025.110803_bib33","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1084\/jem.20190545","article-title":"Gasdermins and their role in immunity and inflammation","volume":"216","author":"Orning","year":"2019","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.exer.2025.110803_bib34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","article-title":"An update on the regulatory mechanisms of NLRP3 inflammasome activation","volume":"18","author":"Paik","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"23","key":"10.1016\/j.exer.2025.110803_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237213","article-title":"Neuroprotective effect of SGLT2 inhibitors","volume":"26","author":"Pawlos","year":"2021","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.exer.2025.110803_bib36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-8587(18)30141-4","article-title":"Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS program randomised clinical trials","volume":"6","author":"Perkovic","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"11","key":"10.1016\/j.exer.2025.110803_bib37","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/IAE.0000000000004252","article-title":"Novel agents in the management of diabetes and risk of worsening diabetic retinopathy","volume":"44","author":"Rajagopal","year":"2024","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.exer.2025.110803_bib38","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2016.03.046","article-title":"Inflammasome complexes: emerging mechanisms and effector functions","volume":"165","author":"Rathinam","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.exer.2025.110803_bib39","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/glia.23727","article-title":"Glia of the human retina","volume":"68","author":"Reichenbach","year":"2020","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.exer.2025.110803_bib40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/APO.0000000000000598","article-title":"Update on retinal vein occlusion","volume":"12","author":"Romano","year":"2023","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"10266","key":"10.1016\/j.exer.2025.110803_bib41","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)31559-2","article-title":"Retinal vascular occlusions","volume":"396","author":"Scott","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.exer.2025.110803_bib42","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1186\/s12967-024-05441-y","article-title":"Insights to Ang\/Tie signaling pathway: another rosy dawn for treating retinal and choroidal vascular diseases","volume":"22","author":"Sha","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.exer.2025.110803_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-vision-091517-034425","article-title":"Microglia in the retina: roles in development, maturity, and disease","volume":"4","author":"Silverman","year":"2018","journal-title":"Annu Rev Vis Sci"},{"issue":"1","key":"10.1016\/j.exer.2025.110803_bib44","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.09.010427","article-title":"Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors","volume":"9","author":"Song","year":"2019","journal-title":"J. Glob. Health"},{"issue":"9","key":"10.1016\/j.exer.2025.110803_bib45","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/dom.14445","article-title":"Risk of diabetic macular oedema with sodium-glucose cotransporter-2 inhibitors in type 2 diabetes patients: a multi-institutional cohort study in Taiwan","volume":"23","author":"Su","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.exer.2025.110803_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.exer.2013.05.018","article-title":"Neuroprotective effect of minocycline in a rat model of branch retinal vein occlusion","volume":"113","author":"Sun","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110803_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101263","article-title":"Targeting inflammasomes and pyroptosis in retinal diseases-molecular mechanisms and future perspectives","volume":"101","author":"Sun","year":"2024","journal-title":"Prog. Retin. Eye Res."},{"issue":"8","key":"10.1016\/j.exer.2025.110803_bib48","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ophtha.2024.01.029","article-title":"Efficacy and safety of faricimab for macular edema due to retinal vein occlusion: 24-week results from the BALATON and COMINO trials","volume":"131","author":"Tadayoni","year":"2024","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.exer.2025.110803_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/life12050692","article-title":"Sodium-glucose Co-Transporter 2 inhibitors reduce macular edema in patients with diabetes mellitus","volume":"12","author":"Tatsumi","year":"2022","journal-title":"Life"},{"issue":"6","key":"10.1016\/j.exer.2025.110803_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/iovs.65.6.19","article-title":"Use of sodium-glucose Co-Transporter 2 inhibitors in patients with type 2 diabetes and the incidence of retinal vein occlusion in Taiwan","volume":"65","author":"Tsai","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110803_bib51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajo.2024.04.010","article-title":"Impact of GLP-1 agonists and SGLT-2 inhibitors on diabetic retinopathy progression: an aggregated electronic health record data study","volume":"265","author":"Wai","year":"2024","journal-title":"Am. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.exer.2025.110803_bib52","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/db22-0970","article-title":"The early pathogenesis of diabetic retinopathy and its attenuation by sodium-glucose transporter 2 inhibitors","volume":"73","author":"Yamato","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2025.110803_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.992937","article-title":"Effects and mechanisms of SGLT2 inhibitors on the NLRP3 inflammasome, with a focus on atherosclerosis","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2025.110803_bib54","article-title":"Quantifying microglia morphology from photomicrographs of immunohistochemistry prepared tissue using ImageJ","volume":"136","author":"Young","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.exer.2025.110803_bib55","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological inhibitors of the NLRP3 inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.exer.2025.110803_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010858","article-title":"Canagliflozin attenuates lipotoxicity in cardiomyocytes by inhibiting inflammation and ferroptosis through activating AMPK pathway","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.exer.2025.110803_bib57","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/iovs.66.5.2","article-title":"Complement C3\/C3aR signaling pathway inhibition ameliorates retinal damage in experimental retinal vein occlusion","volume":"66","author":"Zhao","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525005767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525005767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:03:39Z","timestamp":1781323419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483525005767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":57,"alternative-id":["S0014483525005767"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2025.110803","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canagliflozin inhibits NLRP3 inflammasome activation to protect the retinal neurovascular unit in a mouse retinal vein occlusion model","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2025.110803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110803"}}